Form 8-K - Current report:
SEC Accession No. 0001193125-25-139146
Filing Date
2025-06-11
Accepted
2025-06-11 16:12:42
Documents
14
Period of Report
2025-06-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d948938d8k.htm   iXBRL 8-K 27778
2 EX-99.1 d948938dex991.htm EX-99.1 9968
6 GRAPHIC g948938g0611232200964.jpg GRAPHIC 3282
  Complete submission text file 0001193125-25-139146.txt   157868

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rlay-20250608.xsd EX-101.SCH 2839
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rlay-20250608_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rlay-20250608_pre.xml EX-101.PRE 10805
16 EXTRACTED XBRL INSTANCE DOCUMENT d948938d8k_htm.xml XML 3504
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39385 | Film No.: 251040144
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)